Skip to main content
. 2021 Jul 5;23(7):e25791. doi: 10.2196/25791

Table 1.

Descriptive statistics (N=12).

Variable Values
Age (years), mean (SD) 65.3 (6.2)
Sex, n (%)

Female 5 (42)

Male 7 (58)
Primary diagnosis, n (%)

Lung adenocarcinoma 10 (83)

Lung squamous cell carcinoma 2 (17)
Stage, n (%)

1 (8)

2 (17)

9 (75)
Treatment, n (%)

Target (EGFR-TKIa) 9 (75)

Chemotherapy 3 (25)
Cardiovascular drugs, n (%)

No 6 (50)

Yes 6 (50)
Hypnotics, n (%)

No 10 (83)

Yes 2 (17)
ECOGb, n (%)

1 9 (75)

2 3 (25)

aEGFR-TKI: epidermal growth factor receptor–tyrosine kinase inhibitor.

bECOG: Eastern Cooperative Oncology Group Performance Status.